Publications by authors named "Pavankumar Daultani"
Article Synopsis
- * Researchers conducted a Phase III clinical trial to compare the immunogenicity and safety of two tetravalent inactivated influenza vaccines in healthy children aged 6-35 months.
- * Both vaccines proved to be similarly effective and safe, with high seroprotection rates and comparable adverse events, indicating that the test vaccine Vaxiflu-4 is a viable alternative to the reference vaccine Fluarix Tetra.
Efficacy and Safety of Amorolfine Lotion 0.25% w/v Compared to Amorolfine Cream 0.25% w/w in Patients With Superficial Fungal Infections of the Skin: A Multi-center, Randomized, Open-Label, Active-Controlled, Non-inferiority Phase III Clinical Trial.
Cureus
May 2024
Article Synopsis
- Dermatophytosis is a common fungal infection that requires antifungal treatment, and amorolfine is a new topical option available as a cream or lotion.
- A clinical trial involving 284 patients compared the efficacy and safety of amorolfine lotion and cream, finding that both formulations led to high cure rates after four weeks of treatment.
- The study concluded that the lotion was just as effective and safe as the cream, with mild and manageable side effects reported for both treatments.
A Multicentric, Prospective, Observational, Single-Arm Registry Study to Assess the Clinical Safety and Effectiveness of Thrombophob Ointment (Heparin Sodium + Benzyl Nicotinate) in Indian Patients With Thrombophlebitis.
Cureus
February 2024
Purpose Thrombophlebitis is a frequent intravenous (IV) therapy consequence. Topical heparin for seven days is used as a treatment for thrombophlebitis. This study was performed to evaluate the clinical safety and effectiveness of the combination of heparin sodium & benzyl nicotinate (Thrombophob Ointment, manufactured by Zydus Healthcare Ltd.
View Article and Find Full Text PDFIntroduction: Once-daily inhalers have been shown to improve adherence leading to lesser discontinuation compared to twice- or thrice-daily inhalers in management of asthma. Combination of Vilanterol and Fluticasone Furoate (VI/FF) is approved for management of asthma and COPD and is available as a dry powder inhaler. Pressurized-Metered Dose Inhalers (pMDIs) offer ease-of-use and therapy alternatives for patients with low inspiratory flow.
View Article and Find Full Text PDFLong-term Persistence of Immunogenicity After Primary Vaccination and Response to Booster Vaccination With Typhoid Conjugate Vaccine: Results of a Phase IV Extension Study.
Indian Pediatr
May 2022
Objective: To evaluate the persistence of antibodies three years after primary vaccination with typhoid conjugate vaccine (TCV) of either Cadila Healthcare Ltd. (Cadila-TCV) or Bharat Biotech International Ltd. (Bharat-TCV) administered in a previous phase II/III study, and to study the booster dose response to Cadila-TCV.
View Article and Find Full Text PDFObjective: To compare the immunogenicity and safety of an investigational typhoid Vi conjugate vaccine (Test TCV) with a marketed typhoid Vi conjugate vaccine (Comparator TCV).
Design: Randomized, controlled trial.
Setting: Tertiary care and multispecialty hospitals.